170 related articles for article (PubMed ID: 37223020)
1. Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.
Wang Y; Luo Y; Fu S; He L; Pan G; Fan D; Wen Q; Fan Y
Front Endocrinol (Lausanne); 2023; 14():1095604. PubMed ID: 37223020
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cells.
Li B; Ren B; Ma G; Cai F; Wang P; Zeng Y; Liu Y; Zhang L; Yang Y; Liang H; Zhang R; Deng J
Clin Epigenetics; 2023 Jan; 15(1):10. PubMed ID: 36650573
[TBL] [Abstract][Full Text] [Related]
3. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
5. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
[TBL] [Abstract][Full Text] [Related]
6. Zinc finger and SCAN domain-containing 18 suppresses the proliferation, self-renewal, and drug resistance of glioblastoma cells.
Wang Y; Peng J; Song C; Yang Y; Qin T
Heliyon; 2023 Jun; 9(6):e17000. PubMed ID: 37389038
[TBL] [Abstract][Full Text] [Related]
7. Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance.
Mukherjee N; Dasgupta H; Bhattacharya R; Pal D; Roy R; Islam S; Alam N; Biswas J; Roy A; Roychoudhury S; Panda CK
Biochim Biophys Acta; 2016 Sep; 1862(9):1472-84. PubMed ID: 27208794
[TBL] [Abstract][Full Text] [Related]
8. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling.
Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G
Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470
[TBL] [Abstract][Full Text] [Related]
10. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer.
Xiao Y; Xiang T; Luo X; Li C; Li Q; Peng W; Li L; Li S; Wang Z; Tang L; Ren G; Tao Q
PLoS One; 2014; 9(10):e110990. PubMed ID: 25360542
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
Chen B; Zhang S; Li Q; Wu S; He H; Huang J
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
[TBL] [Abstract][Full Text] [Related]
12. SHISA3, an antagonist of the Wnt/β-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer.
Shahzad N; Munir T; Javed M; Tasneem F; Aslam B; Ali M; Mutahir Z; Akhtar Ali M; Umer M; Ahmad M; Farooq K; Hassan U; Mustafa T; Anjum RS; Shakoori AR
PLoS One; 2020; 15(7):e0236192. PubMed ID: 32692756
[TBL] [Abstract][Full Text] [Related]
13. The initial expression alterations occurring to transcription factors during the formation of breast cancer: Evidence from bioinformatics.
Dong X; Yang Y; Xu G; Tian Z; Yang Q; Gong Y; Wu G
Cancer Med; 2022 Mar; 11(5):1371-1395. PubMed ID: 35037412
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic biomarkers among ICAMs in the breast cancer microenvironment.
Chen H; Pu S; Mei N; Liu X; He J; Zhang H
Cancer Biomark; 2022; 35(4):379-393. PubMed ID: 36373309
[TBL] [Abstract][Full Text] [Related]
15. BTB/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6/ZBTB27.
He J; Wu M; Xiong L; Gong Y; Yu R; Peng W; Li L; Li L; Tian S; Wang Y; Tao Q; Xiang T
Clin Epigenetics; 2020 Jun; 12(1):82. PubMed ID: 32517789
[TBL] [Abstract][Full Text] [Related]
16. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis based on DNA methylation and RNA-seq reveals hypermethylation of the up-regulated WT1 gene with potential mechanisms in PAM50 subtypes of breast cancer.
Ren C; Tang X; Lan H
PeerJ; 2021; 9():e11377. PubMed ID: 33987034
[TBL] [Abstract][Full Text] [Related]
18. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
Li F; Zhang Y; Shi Y; Liu S
Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
[TBL] [Abstract][Full Text] [Related]
20. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
